GlassScriptPhysician profile
Steven M Dandalides
NPI 1679558472
$3,723.22
in general payments reported to CMS, 2019-2025
23 companies · none reported in 2025
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,225 · 2020: $977 · 2021: $1,479 · 2022: $41.82.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,009.39 | 2019-2021 | |
| Janssen Biotech, INC. | $576.24 | 2019-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $459.85 | 2019-2021 | |
| Pfizer INC. | $280.14 | 2019-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $273.54 | 2019-2021 | |
| Gilead Sciences, INC. | $257.68 | 2019-2021 | |
| Celgene Corporation | $183.18 | 2021 | |
| Daiichi Sankyo INC. | $137.81 | 2019-2021 | |
| Qol Medical, LLC | $80.75 | 2019-2021 | |
| Intercept Pharmaceuticals, INC. | $74.41 | 2019-2021 | |
| Shire North American Group INC | $71.63 | 2019 | |
| Amgen INC. | $54.54 | 2020 | |
| Ironwood Pharmaceuticals, INC | $46.11 | 2020-2021 | |
| Redhill Biopharma INC. | $42.18 | 2020-2021 | |
| Nestle Healthcare Nutrition INC. | $41.02 | 2021 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $29.42 | 2019 | |
| Phadia US INC. | $17.96 | 2019 | |
| Romark Laboratories, Lc | $17.58 | 2019 | |
| Covidien LP | $15.60 | 2020 | |
| Ferring Pharmaceuticals INC. | $14.07 | 2019 | |
| Alfasigma USA, INC. | $13.99 | 2020 | |
| Allergan, INC. | $13.16 | 2019 | |
| Organon LLC | $12.97 | 2022 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Dandalides listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.